Kanya Rajangam - Feb 4, 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Pres. & Chief Med. & Dev. Off.
Signature
/s/ Robert Cutler, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Feb 4, 2025
Transactions value $
-$6,074
Form type
4
Date filed
2/6/2025, 07:53 PM
Previous filing
Dec 10, 2024
Next filing
Mar 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNTI Common Stock Sale -$5.28K -1.3K -12.84% $4.07 8.8K Feb 4, 2025 Direct F1
transaction SNTI Common Stock Sale -$795 -182 -2.07% $4.37 8.62K Feb 6, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.